FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog FDA Peptide Category 2 Removal & Public Meeting July 23rd Mansi Hukmani posted on the topic LinkedIn FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas